Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,208,180 | 1,160,547 | 960,960 | 1,052,000 | 717,824 |
| Marketable Securities | 1,024,585 | 2,816,908 | 2,489,760 | 1,417,000 | 1,603,576 |
| Inventories | 2,176,444 | 2,191,276 | 2,106,160 | 2,080,000 | 2,094,284 |
| Income taxes - deferred | N/A | 1,536,448 | 1,439,200 | N/A | 872,676 |
| Other current assets | 5,478,595 | 4,905,998 | 4,916,240 | 6,022,000 | 4,533,371 |
| TOTAL | $13,173,735 | $13,626,786 | $12,608,400 | $10,749,000 | $10,019,252 |
| Non-Current Assets | |||||
| PPE Net | 6,650,214 | 6,467,992 | 6,433,280 | 6,649,000 | 6,860,277 |
| Intangibles | 4,078,000 | 2,141,226 | 1,837,360 | 1,808,000 | 1,851,339 |
| Other Non-Current Assets | 3,289,947 | 332,106 | 3,064,880 | 3,121,000 | 3,234,681 |
| TOTAL | $14,018,160 | $8,941,324 | $11,335,520 | $11,578,000 | $11,946,296 |
| Total Assets | $27,191,895 | $22,568,110 | $23,943,920 | $22,327,000 | $21,965,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 2,094,501 | 1,581,285 | 1,449,840 | 1,551,000 | 2,128,695 |
| Accounts payable and accrued liabilities | 818,854 | 706,443 | 684,880 | 715,000 | 761,871 |
| Other current liabilities | 6,561,878 | 3,322,106 | 3,333,680 | N/A | 3,411,556 |
| TOTAL | $9,508,940 | $8,718,182 | $8,585,360 | $8,808,000 | $9,450,774 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,269,959 | 4,378,903 | 3,646,160 | 3,092,000 | 2,112,866 |
| Other Non-Current Liabilities | 4,016,397 | 2,994,692 | 2,513,840 | 1,490,000 | 1,141,085 |
| TOTAL | $10,114,509 | $7,650,437 | $6,904,240 | $6,131,000 | $4,117,680 |
| Total Liabilities | $19,623,449 | $16,368,619 | $15,489,600 | $14,939,000 | $13,568,454 |
| Shareholders' Equity | |||||
| Common Shares | 1,490,675 | 1,483,269 | 1,485,120 | 1,506,000 | 1,546,453 |
| Retained earnings | 5,577,974 | 4,778,786 | 4,038,720 | 2,946,000 | 3,946,999 |
| Other shareholders' equity | -308,015 | -643,358 | 1,922,480 | 1,905,000 | 1,869,233 |
| TOTAL | $7,309,249 | $5,922,650 | $7,710,080 | $6,581,000 | $7,533,366 |
| Total Liabilities And Equity | $26,932,698 | $22,291,268 | $23,199,680 | $21,520,000 | $21,101,820 |